IRE1-IN-8866
We provide customized and high-quality MKC8866 product for your project.
MKC8866 is a potent and selective IRE1α RNase inhibitor with IC50 of 0.29?μM for human IRE1α in vitro. MKC8866 administered in combination with paclitaxel enhances the effectiveness of paclitaxel and limits tumor regrowth upon cessation of paclitaxel treatment.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View